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Background: Absence of cost-effectiveness (CE) analyses limits the relevance of large-scale nutrition interventions in
low-income countries. We analyzed if the effect of invitation to food supplementation early in pregnancy combined
with multiple micronutrient supplements (MMS) on infant survival represented value for money compared to invitation
to food supplementation at usual time in pregnancy combined with iron-folic acid.
Methods: Outcome data, infant mortality (IM) rates, came from MINIMat trial (Maternal and Infant Nutrition
Interventions, Matlab, ISRCTN16581394). In MINIMat, women were randomized to early (E around 9 weeks of
pregnancy) or usual invitation (U around 20 weeks) to food supplementation and daily doses of 30 mg, or
60 mg iron with 400 μgm of folic acid, or MMS with 15 micronutrients including 30 mg iron and 400 μgm of
folic acid. In MINIMat, EMMS significantly reduced IM compared to UFe60F (U plus 60 mg iron 400 μgm Folic
acid). We present incremental CE ratios for incrementing UFe60F to EMMS. Costing data came mainly from a
published study.
Results: By incrementing UFe60F to EMMS, one extra IM could be averted at a cost of US$907 and US$797 for
NGO run and government run CNCs, respectively, and at US$1024 for a hypothetical scenario of highest cost.
These comparisons generated one extra life year (LY) saved at US$30, US$27, and US$34, respectively.
Conclusions: Incrementing UFe60F to EMMS in pregnancy seems worthwhile from health economic and public
health standpoints.
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The Bangladesh Integrated Nutrition Project (BINP) and
its successor National Nutrition Program (NNP) imple-
mented food supplementation programs for malnourished
pregnant and lactating women and undernourished chil-
dren less than two years of age [1, 2]. These programs
aimed to reduce under-nutrition by improving maternal,
fetal and childhood nutritional status, including birth
weight (BW). In a previous paper we have shown positive
effects of prenatal food supplement on BW among mal-
nourished Bangladeshi women [3], which was similar to
findings in other countries [4–6].
It has been debated whether to move from the rou-
tine iron-folic acid supplementation in pregnancy to
multiple micronutrients (MMS) in low- and middle-
income settings [7]. This motivated UNICEF/WHO/
United Nations University to manufacture MMS for
testing purposes under the assumption that populations
in these countries are deficient in several micronutri-
ents [7]. Effects of prenatal MMS on offspring mortality
have varied, ranging from increased risk of mortality [8,
9], over no difference [10] to significant reductions in
mortality [11]. A meta-analysis concluded that MMS
supplementation in pregnancy does not result in reduc-
tion of stillbirths or neonatal deaths, compared to iron-
folic acid supplementation [12].
These studies were conducted in populations often at
risk of both macro- (food) and micronutrient deficien-
cies and MMS was not given in combination with food
supplements. Prenatal food supplementation in the
Gambia was associated with 46 % reduction in mortal-
ity during the first week of life [13]. A Cochrane sys-
tematic review based on 13 trials reported that a
balanced protein energy supplementation during preg-
nancy improved fetal growth and reduced stillbirth and
neonatal death [14].
In a randomized trial with the acronym MINIMat (Ma-
ternal and Infant Nutrition Interventions, Matlab) we have
shown a substantial reduction in infant mortality (IM)
with early invitation to prenatal food supplementation (E -
around week 9 pregnancy) combined with MMS (EMMS)
compared to invitation to food supplementation at usual
time (U- around week 20) in pregnancy and 60 mg iron
400 μgm folic acid (UFe60F) [15].
Since there are questions on the affordability of
large-scale food supplementation interventions and
whether or not to move from the routine iron folic
acid supplementation to MMS, we examined if EMMS
represented value for money. We present incremental
cost-effectiveness ratios (ICERs) for incrementing usual
invitation to food supplementation combined with iron-
folic acid to invitation to food supplementation early in
pregnancy combined with multiple micronutrients for
women in rural Bangladesh.Methods
Study design and study population
Outcome data came from MINIMat trial (Maternal and
Infant Nutrition Interventions, Matlab, Trial Registration:
ISRCTN16581394). MINIMat was a randomized trial [15],
conducted in Matlab, a sub-district in Chandpur district
in Bangladesh. In Matlab, the International Centre for
Diarrheal Disease Research, Bangladesh (icddr,b) operates
a Health and Demographic Surveillance System (HDSS)
since 1966. Details regarding design, randomization, treat-
ment groups, and study profile of MINIMat study are
published elsewhere [15]. In brief, MINIMat was a ran-
domized factorial experiment, where pregnant women
(n = 4436) irrespective of their nutritional status were ran-
domized to early (E, at about 9 weeks of pregnancy), or
usual invitation (U, at about 20 weeks of pregnancy) to
daily (6 days a week) food supplement and to one of the
three types of micronutrient capsules, 30 mg iron and 400
μgm folic acid, or 60 mg iron and 400 μgm folic acid, or
multiple micronutrients (MMS) with 15 micronutrients
including 30 mg iron and 400 μgm folic acid. The food
supplementation provided about 608 kcal (made of
roasted rice powder 80 g, roasted pulse powder 40 g, soy-
bean oil 6 g and molasses 20 g). MMS contained recom-
mended daily allowances of 13 micronutrients and 30 mg
iron 400 μgm folic acid [7]. This resulted in six inter-
vention groups, EFe30F (n = 739), EFe60F (n = 738),
EMMS (n = 740), UFe30F (n = 741), UFe60F (n = 738),
and UMMS (n = 740). Randomization of invitation to
food supplement was not blinded but that of micronu-
trient supplementation was double-masked. This study
was approved by the icddr,b ethical review committee.
Informed written consent was obtained from all
participants.
Outcome data and alternatives
Outcome data, IM, came from intent-to-treat analysis of
MINIMat trial comparing UFe60F and EMMS arms, HR
0.38 (95 % CI: 0.18 to 0.78) [15]. Therefore, we com-
pared the alternatives UFe60F, and EMMS in MINIMat.
Adherence to food and micronutrients also came from
MINIMat study; 60 food packets and 113 capsules in
UFe60F arm, and 94 food packets and 107 capsules in
EMMS arm [16].
We assumed the effects of MINIMat intervention were
accumulated from June 2002 through June 2004 and this
can be represented by reductions in IM in the EMMS
arm compared to the UFe60F arm.
By using life expectancy (LE) at birth, 70 years in the
year 2012 [17], we calculated the average LY that can be
saved by avoiding one IM; this was 29.99 years when dis-
counted at 3 % and 20.31 years when discounted at 5 %.
Since we adjusted all costs using consumer price index,
to remain consistent we also adjusted the health gains
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this nutrition intervention similarly as with other sectors
of the economy [18].
Time frame
MINIMat intervention was distributed from September
2001 to end of 2003. The costing study was conducted
from October 1999 to March 2000 [19]. In 2002, we
retrieved additional cost data from BRAC, a non-
governmental organization (NGO) responsible for im-
plementation of food supplementation. In 2003 we also
collected the cost data for micronutrients and some staff
salaries from MINIMat administration at icddr,b. We be-
lieve the cost data collected by Khan and Ahmed from
October 1999 to March 2000 [19] and the additional
cost data collected by us in 2002 and 2003 reasonably
represented the same period as the outcome data.
Cost data
The direct cost for the intervention included food and
micronutrient supplements, staff, training and meeting,
administration, capital, community volunteer time, and
recurrent activities. The indirect cost included the cost
of participants’ time.
Most cost data were available from Khan and Ahmed
[19], while data on cost of micronutrients and some staff
costs were obtained from the MINIMat project adminis-
tration. Figures for all cost items from Khan and Ahmed
[19] were converted to Bangladeshi Taka (BDT) 79.3823
per US$1, the average exchange rate for 2013 [20]. Khan
and Ahmed reported costs for NGO run and govern-
ment run community nutrition centres (CNCs). We pre-
sented all costs for these delivery modes as well as under
a hypothetical highest cost scenario combining the high-
est cost for each item presented for NGO run and gov-
ernment run CNCs. For the last, for example, for food
cost we took the figure for NGO run CNCs but for staff
cost we took the figure for government run CNCs.
CNCs operated for malnourished pregnant and lactat-
ing women and children under two years of age. Per day
at the NGO run CNCs, there were 9.36 pregnant women,
9.71 lactating women and, and 10.29 under two-year-olds.
In total 19.07 pregnant and lactating women represented
19.07 adult equivalents and, 10.29 children represented
5.15 adult equivalents equal to 24.22 adult equivalents. This
was because each pregnant or lactating woman was offered
four packets and each child was offered two packets of food
supplement; thus, two children equals to one adult. There
were 7579 (24.22*313) person days per year (313 working
days per year; CNCs were closed on Fridays). Pregnant
women represented 2930 (9.36*313) person days a year and
used about 32 % (9.36/29.36*100) of working time at the
CNC [19]. We assumed pregnant women received compar-
able services as children did, which we believe was aconservative assumption for CE analysis. Therefore, for cal-
culation of food cost we used adult equivalents and for
other costs we used persons contributed by pregnant
women. In total, 37.44 packets (9.36*4) were utilized per
CNC per day by pregnant women, which were 39 % of total
97 (9.36*4 + 9.71*4 + 10.29*2) food packets. For all items,
we calculated cost per CNC per year and then cost per
pregnant woman per day. Food cost was multiplied by 0.39
(fraction of packets used) and, then, divided by 2930 (per-
son days) to obtain costs per pregnant woman per day. For
other items, costs per CNC per year were multiplied by
0.32 (proportion of working time) to represent pregnant
women and, then, divided by 2930 to obtain cost per
pregnant woman per day. In government run CNCs 6.33
pregnant women, 5.29 lactating women, and 4.38 children
were enrolled resulting in 16 persons, 13.81 adult equiva-
lents, and 55.24 food packets consumed. In this situation,
pregnant women consumed 46 % food packets [(6.33*4)/
55.24*100], and used 40 % time [6.33/16*100]. For the
hypothetical highest cost scenario we used proportions of
food consumed and time used in government run CNCs
since this generated the highest cost figures.
Staff cost was from Khan and Ahmed [19], who de-
rived that from the current local salary and benefits of
BINP employees, and evaluated volunteers’ time using
the salary level of similar workers in rural areas. Staff
costs included salaries for the manager (BDT 10,000 per
month), Community Nutrition Organizers, Community
Nutrition Promoters, and helpers. The manager’s (re-
sponsible for NNP-related activities at sub-district level)
salary was retrieved from the cost report of icddr,b. In-
crease in staff ’s salaries over time was accounted for by a
40 % increase in staff salary from 2002. Training and
meeting costs at sub-district level for 2002 were obtained
from BRAC, who also provided administrative cost for
2000 to 2003, which was averaged: these costs at CNC
levels were available from Khan and Ahmed [19]. We ig-
nored administrative costs at BINP/NNP office.
Capital costs, space for CNCs, and instruments for
screening, maternal height and weight measuring scales,
were available from Khan and Ahmed [19]. From this cost
we deducted cost for measuring scales (Salter scale and
bathroom scale for measuring children’s and women’s
weight, respectively) since in MINIMat all women were
offered to participate in food supplementation inter-
vention irrespective of their anthropometry. Khan and
Ahmed calculated the salary of the Community Volun-
teers (women for preparing and serving food supple-
ment) as community-donated time at the wage of helpers
[19], which we considered appropriate: recurrent costs at
the CNC that represented cost related to the goods pro-
cured locally and from outside the local area were avail-
able from Khan and Ahmed [19]. We ignored these costs
for the sub-district, and central level in Dhaka.
Shaheen et al. BMC Pregnancy and Childbirth  (2015) 15:125 Page 4 of 8Participant cost was estimated at cost of a laborer
when labor cost is the lowest [21]. UNICEF supplied
micronutrient capsules for trial purposes; the price was
not subsidized. Assuming economic life of inputs, Khan
and Ahmed [19] annualized all capital costs at 5 % dis-
count rate, evaluated donated materials and resources
using the market price of similar resources in the local
area. We did not do any further discounting but adjusted
all costs to the price levels for 2013 using consumer
price index [17, 22]. All costs are presented in Table 1.Analyses
For ICERs for extra IM averted we calculated the differ-
ence of costs for supplementing 1000 pregnant women in
EMMS and UFe60F arms, difference of IM rates between
these two arms and then divided the cost difference by the
difference of IM rates. For ICERs for LY saved, the same
steps were followed after multiplying the IM averted (IM
rate in UFe60F – IM rate in EMMS) with discounted
figures of LE at birth. For sensitivity analyses, we used the
lower and upper limits of 95 % CI of HR from the intent-
to-treat analyses comparing EMMS and UFe60F arms in
MINIMat, and converted the resulted number of infant
deaths to IM rates. The above-described steps for calculat-
ing ICERs were then followed and ICERs for extra IM
averted and extra LY gained were calculated.Results
Using the adherence levels and costs from Table 1, we
calculated, by using delivery modes NGO run CNC, gov-
ernment run CNC, and a hypothetical highest cost sce-
nario supplementing 1000 pregnant women would cost
US$42,207, US$36,939, and US$47,865 respectively for
UFe60F. These figures were US$66,953, US$58,699, and
US$75,817 for EMMS (Table 2).Table 1 Cost of food supplementation for pregnant women in Bang
nutrition centres (CNSs), government (Govt.) run CNCs, and by a hyp
Cost items NGO run CNC
Food 25.30 (0.3187) [46.02]
Staff 3.09 (0.0389) [5.62]
Training and meeting 0.91 (0.0114) [1.65]
Administration 0.64 (0.0081) [1.17]
Capital (space) 1.17 (0.0147) [2.12]
Community Volunteers’ time 0.65 (0.0082) [1.18]
Recurrent 0.37 (0.0047) [0.67]
Participant time 22.85 (0.2878) [41.57]
Cost/pregnant woman/day for food 54.98 (0.6926) [100 %]
a 1 US$ =79.3823 Bangladeshi Taka (BDT) at exchange rate for the year 2013 (Refer
[% total cost]. Cost per capsule for iron folic acid is BDT 0.457 (US$ 0.00575), and m
for NGO run CNCs, government run CNCs, and under a hypothetical highest cost sc
numbers 15, 17, 19, and 21Incremental cost-effectiveness ratios
The ICERs for one extra IM averted by switching from
UFe60F to EMMS were US$907, and US$797, respect-
ively, for NGO run and government run CNCs (Table 3).
This figure for the hypothetical highest cost scenario
would be US$1024 for one extra IM averted (Table 3).
With 3 % discount rate of LE at birth corresponding fig-
ures for LY saved for switching from UFe60F to EMMS
ranged from US$27 to US$34, at the level of costs by
the above two service delivery modes and by the highest
cost scenario (Table 3). The corresponding LY gained
figures for LE discounted at 5 % rate were, US$45,
US$39, and US$51, respectively.
Sensitivity analyses
The IM rates associated with the lower limit of 95 % CI of
HR from the intent-to-treat analysis showed ICERs for one
extra IM averted by switching UFE60F to EMMS were
US$685, and US$602, respectively for NGO run and gov-
ernment run CNCs, and US$774 for the hypothetical high-
est cost scenario (Table 3). ICERs related to LY saved with
3 % discount rate of LE at birth ranged from US$20 to
US$26 for the above three options, and with 5 % discount
rate of LE at birth ranged from US$30 to US$38 (Table 3).
The IM rates associated with the upper limit of 95 %
CI of HR showed ICERs for one extra IM averted were
US$2577, and US$2266, respectively for NGO run and
government run CNCs; and US$2911 for the hypothet-
ical highest cost scenario (Table 3). Under this circum-
stance, the ICERs for LY saved ranged from US$76 to
US$97 at 3 % discount rate and US$112 to US$143 at
5 % discount rate of LE at birth (Table 3).
Discussion
Our incremental CE analyses have shown by using ac-
tual delivery modes one extra IM could be averted at aladesh by implementation strategy, NGO run community
othetical highest cost scenarioa
Govt. run CNC Highest cost
15.70 (0.1978) [32.70] 30.03 (0.3783) [48.07]
4.78 (0.0602) [9.95] 4.78 (0.0602) [7.65]
1.09 (0.0138) [2.28] 1.13 (0.0142) [1.80]
0.80 (0.0101) [1.66] 0.80 (0.0101) [1.28]
1.35 (0.0170) [2.81] 1.45 (0.0182) [2.31]
0.81 (0.0101) [1.68] 0.81 (0.0101) [1.29]
0.64 (0.0081) [1.33] 0.64 (0.0081) [1.03]
22.85 (0.2878) [47.60] 22.85 (0.2878) [36.58]
48.01 (0.6048) [100 %] 62.47 (0.7869) [100 %]
ence number 20). Costs represent per pregnant woman per day in BDT (US$)
ultiple micronutrients is BDT 1.371 (US$ 0.017272). Calculations are presented
enario combining costs from the first two options. Sources are reference
Table 2 Infant mortality (IM) rates per 1000 live births, adherence to intervention and cost for supplementing each and 1000
pregnant women for NGO run community nutrition centres (CNSs), government (Govt.) run CNCs and a hypothetical highest cost
scenarioa
Alternative IM
rate
Adherence to food
packets
Adherence to micronutrient
capsules
Cost for one woman (US$) Cost for 1000 women (US$)
NGO run
CNC
Govt. run
CNC
Highest
cost
NGO run
CNC
Govt. run
CNC
Highest
cost
UFe60Fb 44.1 60 113 42.207 36.939 47.865 42,207 36,939 47,865
EMMSc 16.8 94 107 66.953 58.699 75.817 66,953 58,699 75,817
aUFe60F = invitation to prenatal food supplementation at usual time in pregnancy (at about week 20) and 60 mg iron 400 μgm folic acid. EMMS = early invitation
to prenatal food supplement (at about 9 week gestation) plus multiple micronutrients (MMS); Cost per pregnant woman per day for food US$0.6926, US$0.6048,
and US$0.7869 for NGO run CNCs, government run CNCs and a hypothetical highest cost scenario, MMS US$0.017272, iron-folic acid US$0.0057574. Sources for
IM rates reference number 15, and adherence to the intervention reference number 16
bcost of supplementing 1000 pregnant women with UFe60F for NGO run CNCs, government run CNCs, and for a hypothetical highest cost scenario were,
US$42,207 [(0.6926*60*1000) + (0.005757*113)*1000)], US$36,939 [(0.6048*60*1000) + (0.005757*113)*1000)], and US$47,865 [(0.7869*60*1000) + (0.005757*113)*1000)],
respectively
ccost of supplementing 1000 pregnant women with EMMS for NGO run CNCs, government run CNCs, and for a hypothetical highest cost scenario were, US$66,953
[(0.6926*94*1000) + (0.017272*107*1000)], US$58,699 [(0.6048*94*1000) + (0.017272*107*1000)], and US$75,817 [(0.7869*94*1000) + (0.017272*107*1000)], respectively
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UFe60F to EMMS in pregnancy. Our analyses have also
shown one extra LY can be saved at a cost of US$27 to
US$30 by switching from UFe60F to EMMS. We con-
sider the amount of expenditures to attain these gains,
which is less than per capita gross domestic product
(GDP) US$958 in the year 2013 in Bangladesh [17] rep-
resents good value for money.
Validity of data
The effect data in the CE analysis are considered to be
valid, as the trial design offered unbiased estimates of
treatment effects. All pregnant women in the area were
invited to participate in the study, and the pool of preg-
nant women under trial was probably representative of
rural settings in Bangladesh, where women in general
are short, and there is occasional food insecurity. There-
fore the ICERs presented may be considered relevant for
similar settings. The cost data were collected within the
time frame and situation similar to that of the MINIMat
trial and we believe it reasonably represents costs in-
curred by these interventions.
Explaining the results and comparison with other studies
As the overall cost of these programs is high, an evalu-
ation by Hossain et al. questioned the affordability and
cost-effectiveness of the program [23]. By design that
ecological study compared childhood nutritional status
in BINP and non-BINP areas and did neither provide in-
formation on baseline nutritional status, nor did it con-
trol for confounding factors. Further, pregnant women
were ignored when investment for them is likely to incur
positive effects over generations. Thus, we consider the
evaluation by Hossain et al. questioning the US$60 million
budget as erroneous and incomplete.
In a micronutrient trial [8] conducted in the neighbor-
ing country Nepal, the study participants were ruralpregnant women without any inclusion criteria related
to their nutritional status and the authors indicated in-
creased risk of perinatal mortality associated with pre-
natal MMS supplementation compared to iron-folic acid
[8]. In a cluster-randomized trial in Indonesia, prenatal
MMS supplementation compared to iron-folic acid was
associated with 18 % reduction of IM [11]. In MINIMat,
offspring mortality decreased for infants in EMMS arm
compared to UFe60F arm [15] and larger reductions oc-
curred for that intervention among women having lower
education [16]. The difference between the above trials
and MINIMat is that invitation to food supplementation
early in pregnancy is combined with the multiple micro-
nutrients, and the reduction in mortality in MINIMat
was found as a combined effect of early food and MMS.
Our results indicate the better survival among infants is
the effects of increased food intake from around week
10 in pregnancy plus the addition of 15 micronutrients
from around week 14 on fetal health.
The cost per extra IM averted estimates, US$757 to
US$907, from government run and NGO run CNCs are
less than per capita GDP, US$958, in Bangladesh in the
year 2013 [17], which are within the threshold for relative
cost-effectiveness of an intervention suggested by the
Commission of Macroeconomics and Health [24]. The
Commission sets threshold value as less than GDP highly
cost effective and 1 to 3 times GDP cost effective [24].
Our costs per extra LY saved estimates are far below the
per capita GDP.
A community based newborn care intervention in
Bangladesh has shown that a neonatal death could be
averted at a cost of US$ 2939 [25], which is much higher
than our estimates. Further, our cost per one extra IM
averted figures is lower than that reported by the World
Bank in an evaluation of BINP: US$2300 (lower esti-
mate) and US$4100 (upper estimate) as the cost for
death averted [26], and is within the range suggested for
Table 3 Incremental cost-effectiveness ratios (ICERs) for cost per extra infant mortality (IM) averted and extra life year (LY) saved: for NGO run community nutrition centres
(CNSs), government (Govt.) run CNCs and for a hypothetical highest cost scenarioa
Switching
alternatives
Incremental
IM averted
Incremental Costs (US$) ICERs for one extra unit of gain (US$)
IM averted LY savedb LY savedc
NGO run
CNC
Govt. run
CNC
Highest
cost
NGO run
CNC
Govt. run
CNC
Highest
cost
NGO run
CNC
Govt. run
CNC
Highest
cost
NGO run
CNC
Govt. run
CNC
Highest
cost
UFe60F to
EMMSd
27.3 (44.1 −
16.8)
24,746 (66,953 −
42,207)
21,760 (58,699 −
36,939)
27,952 (75,817 −
47,865)
907
(24,746/
27.3)
797
(21,760/
27.3)
1024
(27,952/
27.3)
30
(24,746/
819)
27
(21,760/
819)
34
(27,952/
819)
45
(24,746/
554)
39
(21,760/
554)
51
(27,952/
554)
UFe60F to
EMMSe
Lower limit 36.14 (44.1 −
7.96)
24,746 (66,953 −
42,207)
21,760 (58,699 −
36,939)
27,952 (75,817 −
47,865)
685
(24,746/
36.14)
602
(21,760/
36.14)
774
(27,952/
36.14)
23
(24,746/
1084)
20
(21,760/
1084)
26
(27,952/
1084)
34
(24,746/
734)
30
(21,760/
734)
38
(27,952/
734)
Upper limit 9.60 (44.1 −
34.50)
2577
(24,746/
9.60)
2266
(21,760/
9.60)
2911
(27,952/
9.60)
85
(24,746/
288)
76
(21,760/
288)
97
(27,952/
288)
126
(24,746/
195)
112
(21,760/
195)
143
(27,952/
195)
a UFe60F = invitation to prenatal food at usual time in pregnancy (at about 20 week) plus 60 mg iron 400 μgm folic acid, EMMS = early invitation to prenatal food supplement (at about 9 week) plus multiple
micronutrients (MMS); IM rates per 1000 live births in UFe60F 44.1, and EMMS 16.8 [reference number 15]. LY saved = IM averted* life expectancy (LE) at birth [70 years in 2012, reference number 17] discounted at 3 %
and 5 %, present value 29.99 and 20.31 years, respectively. Because of rounding, some estimates are same
b Based on LY saved when LE at birth discounted at 3 %, present value 29.99 years; moving from UFe60F to EMMS, 27.3*29.99 = 819 years
c Based on LY saved when LE at birth discounted at 5 %, present value 20.31 years; moving from UFe60F to EMMS, 27.3*20.31 = 554 years
d ICER for moving from UFe60F to EMMs using the point estimate HR, 0.38 (95 % CI: 0.18 to 0.78)
e ICERs for moving from UFe60F to EMMs using the lower and upper limits of 95 % CI of HR. The lower limit of 95 % CI of HR (0.18) is related to 4.74 infant deaths [Total deaths 10 out of 595 live births; 10/0.38*0.18 =
4.74] resulting in IM rate of 7.96/1000 live births (4.74/595*1000 = 7.96); the upper limit (0.78) is related to 20.53 deaths [10/0.38*0.78 = 20.53] resulting in IM rate 34.50/1000 live births (20.53/595*1000 = 34.50). Death
rates in arms EMMS, 16.8/per 1000 live births and UFe60F, 44.10/1000 live births (reference number 15). LYs saved from lower limit of HR at 3 % live expectancy at birth, 36.14*29.99 = 1084, and at 5 % discount rate of
life expectancy at birth, 36.14*20.31 = 734. These figures using upper limit of HR were, 9.60*29.99 = 288, and 9.60*20.31 = 195, respectively
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average 2100/death averted) [27]. Further, our estimates
US$27 to USS30 per LY saved for switching from
UFe60F to EMMS are lower than US$211 per LY saved
from participatory women’s group intervention in Nepal
[28]. The cost of implementation could possibly be re-
duced through combining the increment into a package
with other services for pregnant women. But this is
likely to increase workload, and would require increased
capacity in the perinatal services provided by primary
health centres and would entail additional monitoring.
A recent study indicated that monitoring and start-up
costs might not be trivial [29]. The costing study by
Khan and Ahmed has shown though higher percentage
of target population was enrolled in NGO run CNCs, ac-
tual show up of enrollees was higher in government run
CNCs, 60 % vs., 78 % [19]. This implies a reasonable
participation and effect can be expected if interventions
are delivered through government run CNCs where
monitoring is an inbuilt mechanism for all perinatal ser-
vices. In the costing study, to a large extent, the start-up
costs were covered both when delivered through NGO
and government run CNCs.Cost and effect variation, and implications for resultant ICERs
We presented cost per pregnant woman for NGO run
and government run CNCs, and for a hypothetical high-
est cost scenario. Since food cost comprises the largest
component cost, low food cost if delivered through gov-
ernment run CNCs resulted in substantially lower ICERs
for extra IM averted compared to ICERs for NGO run
CNCs and the hypothetical highest cost scenario. These
differences are also evident in case of one extra IM
averted based on effect estimates from the upper and
lower limits of 95 % CI of HR comparing UFe60F and
EMMS. Depending on prevalence of risk factors for IM
and responsiveness of these risk factors to prenatal food
and micronutrient interventions, the effect estimates as
captured in 95 % CI of HR may result in substantial re-
ductions in IM from prenatal food and micronutrient in-
terventions and highly favorable ICERs may be observed.
Since actual show-ups of enrollees were higher for gov-
ernment run CNCs [19] possibly due to the availability
of other maternal and child health services, the ICERs
we presented indicate favorable outcomes with reason-
able costs may be expected by scaling up prenatal food
and micronutrient interventions in government health
care system.Limitations
We do not have data on treatment cost for the side effects
of micronutrients and other intangible costs. Similarly, our
analysis is based on one positive outcome, IM reduction;we did not include other tangible and intangible benefits of
the intervention that may have occurred [30].
Conclusions
Our analysis shows that at US$797 to US$907 and US$27
to US$30 respectively, one extra IM can be averted and
one extra LY can be saved by switching from invitation to
food supplementation at usual time in pregnancy and
iron-folic acid supplementation to an early initiation to
food supplementation combined with MMS. These figures
are below per capita GDP, US$958, for the year 2013 in
Bangladesh. Compared to the economic venture, the
health gains can be considered high in low-income coun-
tries and in the global context. These results should aid
decision-making that prioritizes pregnant women’s health.
Further research is needed to understand if better infant
survival can be achieved by improving diet during early
pregnancy.
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